Phibro Animal Health | PAHC - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Align Technology USD 864.87M 2.84M 2026-06
ANI Pharmaceuticals USD 562.3M 344.37M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Eli Lilly USD 10.02B 285M 2026-03
Henry Schein USD 3.17B 77M 2026-03
Idexx Laboratories USD 778.23M 3.26M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Pacira USD 172.75M 20.93M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 206.12M 5.17M 2026-03
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Zoetis USD 3.23B 1.68B 2026-03